Document:

Employment Agreement

 Exhibit 10.1 
  
 EMPLOYMENT AGREEMENT 
  
 We are delighted to document your [Frank J. Cesario] relationship with ISCO International as Chief Financial Officer, reporting to Chief Executive Officer John Thode. In
this letter I would like to present the terms of your employment with ISCO. 
  
 Your salary will be $175,000 per year, earned and paid on ISCO’s regular payroll cycle. You will be eligible for a cash bonus of up to 25% of your annual salary, based on the achievement of mutually agreed upon goals. You will remain
eligible to participate in the February 2006 payouts of the incentive cash and equity programs. Subject to Board approval, I anticipate those totals to be $15,000 in cash bonus and a grant of 250,000 shares of ISCO common stock. 
  
 We will recommend to our Board of Directors that you be granted restricted common stock in
the amount of 250,000 shares in 2006, to vest on a quarterly basis over two years. You would earn an additional 125,000 restricted shares of common stock if the company exceeds its annual business plan by 50%, or 250,000 restricted shares of common
shares of common stock if the company exceeds its annual business plan by 100%. These additional shares, if earned, would vest semi-annually over a two year period. 
  
 In recognition of your capabilities and experience, ISCO offers you three months of severance if you are terminated for any reason other
than Good Cause, contingent upon your execution of a release and non-disparagement agreement. You would receive your base salary during the severance period, and receive any bonus earned during your employment period as well as all vested equity
awards as of your termination date. Good Cause, as that term is generally defined, includes (1) the refusal, failure or inability to perform one’s duties, (2) willful misconduct or gross negligence in the carrying out one’s
duties, (3) a felony conviction (or plea of nolo contendre to a like charge), or (4) the willful violation of ISCO’s code of conduct or other policies and procedures subject to the terms of those policies and procedures. 

 
 General 
  
 Employees are paid bi-weekly, every other Friday. Your employment will continue “at will” until either you or ISCO notifies the
other of termination, subject to the severance benefit listed above. 
  
 ISCO will
also provide you with its customary benefits package, which includes a medical, RX, dental, vision, life and disability plan. These benefits are effective upon your hire date. You may also participate in the 401(k) savings plan (including 50% match
of employee contributions up to 3% of employee salary) and/or Flexible Spending Account (Section 125/Cafeteria Plan) on the same terms as are provided to other ISCO employees. You will be eligible for vacation days according to company policy. As an
ISCO employee, you will have access to information about the properties and operations of ISCO, which are confidential in nature. Your work on behalf of ISCO may also give rise to patentable or otherwise proprietary inventions. Please note that you
have already executed ISCO’s standard Confidentiality and Proprietary Rights Agreement, which remains in full force and effect. 
  
 I am pleased to present these terms to you, Frank. If you accept them, please sign a copy of this letter and return it to my attention, retaining the other copy for your
files. 
  

	
	 Sincerely,

	
	 John Thode

	
	 President and CEO

  

					
	Accepted and Agreed:	 	 /s/ Frank Cesario                        

	 	Date: February 6, 2006Employment Letter Agreement with David Carnevale dated January 12,2006

 Exhibit 10.8 
  
 January 12, 2006 
  
 David Carnevale 
  
 Dear David, 
  
 American Technology Corporation
(“Company”) is very pleased to confirm our offer of employment. This offer is contingent upon satisfactory results of all reference, education, and background checks and is based on the following terms and conditions: 
  

			
	Title:	 	Vice President, Marketing
		
	Reporting To:	 	John Zavoli, President and Chief Operating Officer
		
	Start Date:	 	January 30, 2006 or earlier
		
	Salary:	 	Your starting salary as an exempt employee will be $7,500.00 gross Semi-monthly or $180,000 annually.
		
	Stock Options:	 	Management will recommend to the Compensation Committee at its first meeting following your start date, that you be granted stock options to purchase 100,000 shares of common stock. These
options are presently available to accommodate this recommendation. The Compensation Committee has the discretion to approve or deny the grant. The recommended options will have an exercise price equal to the fair market value of our common stock
(determined in accordance with our 2005 Stock Option Plan) on the date the Compensation Committee approves the grant, and will be exercisable for five (5) years after grant, subject to earlier termination as set forth in the 2005 Stock Option Plan.
The recommended options will vest over four (4) years with 25% vesting on the first anniversary of grant, and then in equal quarterly installments over the following three years of continuous service with the Company.
		
	Health Benefits:	 	The Company offers a comprehensive benefits plan that includes medical, dental, vision, short-term disability, long-term disability and life insurances. The company pays for 90% of the HMO
medical insurance premiums (including dependents). The employee can elect PPO coverage by paying the difference in cost. The company pays for dental, vision, short-term disability, long-term disability and life insurances. Benefits begin the first
day of the month following your hire date.
		
	Paid Time Off & Holidays:	 	You will receive 15 days of accrued Paid Time Off (PTO) annually, in use for vacation or for personal time off. PTO hours are accrued per pay period. Any hours in excess of 200 will be paid
out in the first pay period of December.
		
	 	 	The Company offers 9-paid holidays each calendar year. You must be on active status the day before and the day after the holiday to receive holiday pay.

			
	Retirement:	 	A 401k package is available with multiple investment options and the company matches 25% of the employee’s deferral up to 6% of your annual earnings. (Note: Some IRS limitations may
apply.)
		
	Arbitration:	 	As a contingency of this offer, you will be required to sign the attached Mutual Agreement to Arbitrate (“Arbitration Agreement”).

  
 Due to the enactment of the
Immigration Reform and Control Act of 1986, this offer is contingent on your ability to produce acceptable documentation verifying your eligibility to work in the United States. You will be required to present the necessary documents on the day you
begin work at American Technology Corp. 
  
 Additionally, as a condition of this
offer and of your employment with American Technology Corp., you will be required to preserve the Company’s proprietary and confidential information and you must comply with the Company’s policies and procedures. Accordingly, you will be
required to execute the Company’s Non-Disclosure Agreement on your first date of employment. 
  
 If accepted, your employment will be at-will with no specified period or term of employment. This means that either you or the Company may terminate employment at anytime, with or without reason. The Company may also
transfer, promote, demote or otherwise alter your position and/or status at any time and for any reason. An employment agreement for a specified period of time, which contradicts this at-will agreement, may only be entered into in writing, signed by
the President of the Corporation. 
 Please acknowledge your acceptance of our offer by signing below and returning a copy of this letter to us. 

 
 If there are any questions, please do not hesitate to call me. 
  
 Yours truly, 
  
 /s/ John Zavoli 
  
 John Zavoli 
 President/COO 
  
 I understand and agree to the terms and conditions set forth in this letter. I further
understand that any misrepresentations that I have made on my employment application or resume can result in termination. I acknowledge that no statement contradicting this letter, oral or written, has been made to me, that I am not relying on any
statement or term not contained in this letter, and that no agreements exist which are contrary to the terms and conditions set forth in this letter. 
  

			
	Accepted by:    /s/ David Carnevale	  	Date:    January 12, 2006Amended and Restated Membrane Manufacture

 EXHIBIT 10.1 
  
 AMENDED AND RESTATED 
 MEMBRANE MANUFACTURE AND SUPPLY AGREEMENT 
  
 This Amended and Restated Membrane Manufacture and Supply Agreement (this “Agreement”) is entered into effective as of November 30, 2005 (the “Effective Date”), between Millipore Corporation
(“Millipore”), a Massachusetts corporation with its principal place of business at 290 Concord Road, Billerica, MA 01821, and Entegris, Inc. (“Entegris”), a Delaware corporation with its principal place of business at 3500 Lyman
Boulevard, Chaska, MN 55318. 
  
 RECITALS 
  
 1. Millipore and Mykrolis Corporation (“Mykrolis”) entered into a
Master Separation and Distribution Agreement, dated as of March 28, 2001 (the “Master Agreement”), under which, among other things, the business of Millipore’s Microelectronics Division was transferred to Mykrolis at the
Separation Date and Mykrolis was thereafter spun-off to become an independent company effective February 27, 2002. 
  
 2. Pursuant to the Master Agreement, Millipore and Mykrolis entered into a Membrane Manufacture and Supply Agreement dated as of the Separation Date (the
“Old Agreement”) which among other things provided for the manufacture and supply of certain membranes that are used by and incorporated into products of both Millipore and Mykrolis, so as to appropriately ensure both Millipore and
Mykrolis a continuing supply of such membranes; by its terms the Old Agreement is to continue in effect until March 31, 2006. 
  
 3. Millipore and Entegris (which is the surviving corporation of the merger of Mykrolis and Entegris, Inc., a Minnesota corporation, which was completed
as of August 6, 2005) wish to amend and restate certain provisions of the Old Agreement (which was assigned, by operation of the merger, to Entegris) and to cancel and replace the Old Agreement as of the Effective Date with this Agreement which
is intended to operate as a stand alone agreement independent of the Master Agreement. 
  
 NOW, THEREFORE, in consideration of the foregoing and the covenants and agreements set forth below, the parties hereto agree as follows: 
  

	1.	DEFINITIONS 

  
 The following terms shall have the meanings assigned to them below whenever they are used in this Agreement including the Exhibits and Annexes hereto. Terms defined
elsewhere in this Agreement shall have the meaning ascribed thereto at the location of their definition. Except where the context otherwise requires, words imparting the singular shall include the plural and vice versa, words denoting any gender
shall include all genders and words denoting persons shall include bodies corporate and vice versa. 
  

 Page 1 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

 “Affiliated Company” of one of the parties shall mean any entity that controls, is
controlled by, or is under common control with such party. As used herein, “control” means the possession, directly or indirectly, or the power to direct or cause the direction of the management and policies of such entity, whether through
ownership of voting securities or other interests, by contract or otherwise. 
  
 “Confidential Information” shall have the meaning set forth in Section 13.1 hereof. 
  
 “Entegris Core Business” shall mean: (i) the IC MANUFACTURING INDUSTRY including
companies that manufacture integrated circuits, semiconductors, semiconductor chips and other microelectronics components, flat panel displays, solar cells and fiber optic cables, optical coatings, coated optical lenses and coated optical fibers;
(ii) the IC OEM EQUIP & MATERIALS MFG. INDUSTRY including companies that manufacture equipment for the fabrication and processing of semiconductors and
integrated circuits for sale to companies in the IC Manufacturing Industry as well as companies that integrate a number of components into subsystems sold to OEM equipment manufacturers for incorporation into semiconductor fabrication equipment, as
well as companies that manufacture, process and supply liquids, gases, conductive materials and other advanced materials to the IC Manufacturing Industry and which provide products and systems to purify, monitor and control atmospheric conditions in
clean room manufacturing environments of the IC Manufacturing Industry; and (iii) the IC RESEARCH LABORATORY INDUSTRY including university, governmental and commercial laboratories and
research operations that research and/or develop innovations in the structure and composition of integrated circuits, the processes and materials used to manufacture integrated circuits and new forms of integrated circuits. 
  
 “Entegris Equipment” shall have the meaning set forth in
Section 3.1.2 hereof. 
  
 “Entegris Permitted
Persons” shall have the meaning set forth in Exhibit B. 
  
 “Equipment” shall mean the Entegris Equipment and the Millipore Equipment collectively. 
  
 “Flat Sheet UPE Membranes” shall mean rollstock UPE Membranes typically less than 300 microns in sheet thickness including both phobic
and philic Membranes as produced at the Premises pursuant to the Old Agreement immediately prior to the Effective Date, or as modified as provided in this Agreement. 
  
 “Information” shall mean business information, technical information and data, know-how, research
information and data, formulae and other information, whether or not patentable or copyrightable, in written, oral, electronic or other tangible or intangible forms, stored in any medium, including studies, reports, records, books, contracts,
instruments, surveys, discoveries, ideas, concepts, know-how, techniques, designs, specifications, drawings, blueprints, diagrams, models, prototypes, samples, flow charts, 

  

 Page 2 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

 
data, computer data, disks, diskettes, tapes, computer programs or other software, marketing plans, customer names, communications by or to attorneys
(including attorney-client privileged communications), memos and other materials prepared by attorneys or under their direction (including attorney work product), and other technical, financial, employee or business information or data. 

 
 “Lease” shall mean the lease of the Premises as set forth
in Section 2 hereof and in the Lease terms set forth in Exhibit B hereto. 
  
 “Machines” shall have the meaning set forth in Section 7.1 hereof. 
  
 “Machine Hourly Rates” shall have them meaning set forth in Section 7.1. hereof. 
  
 “Membranes” shall mean UPE Membranes and Other Membranes as
well as any other membranes or materials that the parties may hereafter agree to add to this definition of Membranes. 
  
 “Millipore Core Business” shall mean: (i) the BIOPHARM INDUSTRY including
pharmaceutical/biotechnology and genetic engineering companies as well as manufacturers of cosmetics, medical devices, diagnostic products and clinical analytical products; (ii) the LAB & LIFE
SCIENCE RESEARCH INDUSTRY including government, university and private research and testing analytical laboratories for proteomic, genomic, microbiological and similar research and analysis as well as
for environmental research and analysis; and (iii) the FOOD & BEVERAGE INDUSTRY including companies that manufacture or process foods and beverages including dairy products,
beer, wine, juice and soft drink manufacturers and bottled water companies. 
  
 “Millipore Equipment” shall have the meaning set forth in Section 3.1.3 hereof. 
  
 “Other Flat Sheet UPE Membranes” shall mean Flat Sheet UPE Membranes other than Treated Flat Sheet UPE Membranes. Other Flat Sheet UPE
Membranes include, as of the Effective Date, those Membranes listed under the heading “Other Flat Sheet UPE Membranes” in Exhibit A hereto. 
  
 “Other Membranes” shall mean those membranes listed under the heading “Other Membranes” in
Exhibit A hereto, each as produced pursuant to the Old Agreement immediately prior to the Effective Date, or as modified as provided in this Agreement. 
  
 “Other Membrane Products” shall mean devices or other products which include one or more Other Membranes as
a material or component. 
  
 “Other UPE
Membranes” shall mean all UPE Membranes other than Treated Flat Sheet UPE Membranes. 
  

 Page 3 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

 “Other UPE Products” shall mean devices or other products which include Other UPE
Membranes as a material or component. 
  
 “Premises” shall have the meaning set forth in Exhibit B. 
  
 “Releases” shall mean any purchase orders or other documents of purchase that Millipore may place with Entegris for UPE Membranes, or that Entegris may place with Millipore for Other Membranes.

  
 “Rent” shall have the meaning set forth in
Exhibit B. 
  
 “Separation Date” shall
mean March 31, 2001. 
  
 “Subsidiary” of one
of the parties shall mean any entity that is controlled by such party. As used herein, “control” of an entity means the possession, directly or indirectly, or the power to direct or cause the direction of the management and policies of
such entity, whether through ownership of voting securities or other interests, by contract or otherwise. 
  
 “Supplement” shall mean the schedule of supplemental terms and conditions specifying detailed provisions to implement the contractual
commitments set forth in this Agreement relating to membrane manufacturing operations and membrane manufacturing process improvements which is attached to this Agreement as Exhibit C. 
  
 “Supplied Party” shall mean a party to this Agreement that
orders certain Membranes pursuant to this Agreement and to whom such Membranes are sold. 
  
 “Supplying Party” shall mean a party to this Agreement that manufactures certain Membranes ordered by the other party pursuant to this Agreement and that sells such Membranes to the other party.

  
 “Term” or “Term of this
Agreement” shall mean the effective period of this Agreement as set forth in Section 6 hereof. 
  
 “Treated Entegris Membranes” shall mean Treated Flat Sheet UPE Membranes and Treated Other Entegris Membranes. 
  
 “Treated Entegris Products” shall mean devices or other
products which include Treated Entegris Membranes as a material or component. 
  
 “Treated Other Entegris Membranes” shall mean those Entegris membranes that are chemically treated using Millipore’s VMF4 Line or using Millipore’s patented VMF4 technology, including, as of
the Effective Date, those membranes listed under the heading “Treated Other Entegris Membranes” in Exhibit A hereto. 
  

 Page 4 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

 “Treated Flat Sheet UPE Membranes” shall mean Flat Sheet UPE Membranes that are
chemically treated using Millipore’s VMF4 Line or using Millipore’s patented VMF4 technology, including, as of the Effective Date, those Membranes listed under the heading “Treated Flat Sheet UPE Membranes” in Exhibit
A hereto. 
  
 “UPE Membranes” shall mean
microporous membranes produced from an ultrahigh molecular weight polyethylene material by a melt cast process, as produced pursuant to the Old Agreement at the Premises immediately prior to the Effective Date, or as modified as provided in this
Agreement. 
  
 “UPE Products” shall mean devices
or other products which include UPE Membranes as a material or component. 
  

	2.	LEASE OF THE PREMISES 

  
 In order to enable Entegris to manufacture UPE Membranes, including Treated
Flat Sheet UPE Membranes and Other Flat Sheet UPE Membranes, and Treated Other Entegris Membranes in the same production areas at Millipore’s facility at 80 Ashby Road, Bedford MA. and/or such additional, reduced or substituted areas all as
described in greater detail in Exhibit B hereto, and with the same processes as such UPE Membranes and Treated Other Entegris Membranes were manufactured prior to the Effective Date (both (i) for its own use and sale and for its sale of UPE
Products and (ii) for supply of Flat Sheet UPE Membranes to Millipore as provided in this Agreement), Millipore and Entegris agree to the arrangements regarding Entegris’ use of the Premises as are set forth in Exhibit B hereto.

  

	3.	OWNERSHIP AND USE OF THE EQUIPMENT

  

	3.1.	Ownership. For purposes of clarification, the parties acknowledge and agree that: 

  

	 	3.1.1.	All right, title and interest in and to the following equipment currently used in the manufacture of UPE Membranes and/or Treated Other Entegris Membranes, was with Mykrolis
pursuant to the terms of the Old Agreement, and now exists with, and is solely owned by Entegris: 

  

							
	   Item#  

	  	     Description    

	  	     Current Location    

	  	Quantity

	1.	  	Slurry Mixing Vessels	  	Bldg C – Mix Room	  	2
				
	2.	  	Extrusion Line & support equipment (cranes, vents etc.)	  	Bldg D – 101	  	1
				
	3.	  	NZE Extractors & support equipment (scales, vents etc.)	  	Bldg C – 103	  	2

  

 Page 5 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

							
	4.	  	Release/Testing Equipment (porosimeter, flow stands, VBP stands, digital dimension equipment)	  	Bldg D-101	  	1
				
	5.	  	Monomer Chemical Mixing Vessel (for philic Flat Sheet UPE Membranes)	  	Bldg C-Mix Room	  	1
				
	6.	  	MSR Batch Extractors & support equipment (cranes, LS-15, etc.)	  	Bldg D-101	  	3
				
	7.	  	Release/Testing Equipment (flow stands, VBP stands, digital dimension equipment)	  	Bldg F-Cell 5	  	1
				
	8.	  	CUPE Mix/recirculation Pumps	  	Bldg C-Mix Room	  	2
				
	9.	  	NZE Chiller Loop (~ 100 Tons)	  	Bldg C-Roof	  	1

  

	 	3.1.2.	The following equipment currently used in the manufacture of UPE Membranes and/or Treated Other Entegris Membranes (collectively with the equipment listed in Subsection 3.1.1
above, the “Entegris Equipment”) was purchased by Mykrolis during the term of the Old Agreement and is solely owned by Entegris: 

  

							
	   Item#  

	  	     Description    

	  	     Current Location    

	  	Quantity

	1.	  	Oil Mist Collector (and duct/hood)	  	Bldg D-101	  	1
				
	2.	  	7 Ton Edwards Chiller	  	Bldg D-outside	  	1
				
	3.	  	Tiyoda-Serec Extractor	  	Bldg F-Cell 5	  	1
				
	4.	  	Tiyoda-Serec Ext 42 Ton Chiller	  	Bldg C-roof	  	1

  

	 	3.1.3.	All right, title and interest in and to the following equipment currently used in the manufacture of UPE Membranes and/or Treated Other Entegris Membranes (collectively, the
“Millipore Equipment”) is solely owned by Millipore: 

  

							
	   Item#  

	    	     Description    

	    	     Current Location    

	  	Quantity

	1.	    	Slurry Mix Stations; Control Modules 1-3	    	Bldg C -105	  	3
				
	2.	    	Film 1 Annealing Line	    	Bldg. C-123	  	1
				
	3.	    	VMF 4 Line (chemical modification)	    	Bldg. C-124	  	1
				
	4.	    	Testing: Flow, Wet Time, Stability	    	Bldg.C-124	  	various
				
	5.	    	Monomer Chemical Mixing Stations 4-6	    	Bldg. C-105	  	3

  

 Page 6 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	3.2.	Use of Millipore Equipment and Support. At all times during the Term of this Agreement, Millipore shall provide Entegris with access to and use of the
Millipore Equipment, each as necessary for use in the manufacture of UPE Membranes or Treated Other Entegris Membranes in accordance with Article I of the Supplement. Entegris shall pay Millipore Machine Hourly Rates as set forth in Section 7.1
below with respect to the use of the Millipore Equipment. At all times during the Term of this Agreement Millipore will provide a reasonable level of operational assistance and general technical support assistance in resolving technical problems in
UPE Membrane manufacture in accordance with Article I of the Supplement Millipore shall be responsible for maintaining the Millipore Equipment in its current operational capability, and Entegris shall be responsible for maintaining the Entegris
Equipment in its current operational capability and condition, in each case as specified in Article I of the Supplement, unless the parties agree in writing during the Term of this Agreement to alter such maintenance responsibilities. To the extent
Millipore provides extraordinary services to Entegris, such services will be charged in accordance with the rate structure specified in Section 7.3 of the Agreement. 

  

	4.	MANUFACTURE OF MEMBRANES 

  

	4.1.	Membrane Manufacturing Operations. Millipore and Entegris agree that Membrane manufacturing operations during the Term of this
Agreement shall be carried out in accordance with this Section 4 and with Article I of the Supplement. 

  

	4.2.	Guaranteed Capacity. At all times during the Term of this Agreement: 

  

	 	4.2.1.	Millipore agrees to have VMF4 Line capacity sufficient to handle projected philic Membrane volumes hereunder of up to 280,000 feet (~800 hours) per quarter. If necessary and
at Millipore’s discretion, this capacity can be accomplished by either moving Millipore products (i.e. products other than the Membranes covered by this Agreement) to Millipore’s MML hydrophilization equipment or by moving philic Membranes
covered by this Agreement to the MML hydrophilization equipment if mutually agreed upon with cost impact to be agreed upon in advance. 

  

	 	4.2.2.	Millipore agrees to have Film 1 Annealing Line processing capacity sufficient to handle projected phobic Membrane volumes hereunder of up to 3,200,000 feet (~1400 hours) per
quarter. 

  

	 	4.2.3.	Entegris agrees to generally schedule operations in alignment with Millipore’s plan for shutdown periods and holidays. However, it is acknowledged and agreed that there
will be times of high demand where Entegris will be required to run the Entegris Equipment during these times. In such cases, Millipore and Entegris will mutually agree on a plan allowing for high utilization of the Entegris Equipment.

  

 Page 7 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	4.2.4.	Subject to any new or changed restrictions imposed by the applicable air emission permit(s), Entegris agrees to have sufficient capacity, across all relevant process steps,
to meet Millipore’s projected demand for phobic UPE Membranes as follows: 

  

			
	         Guaranteed Capacity Per Calendar
Quarter        

	   Calendar Year  

	 	     Feet    

	2006	 	250,000
	2007	 	300,000
	2008	 	325,000
	2009	 	350,000
	2010	 	350,000

  

	 	  	If necessary but at Millipore’s discretion this capacity can be accomplished by moving production in excess of current manufacturing capacity to new equipment acquired by
Entegris to increase capacity. Millipore expressly acknowledges that the above stated capacities per quarter represent the capability of existing equipment located at the Premises as of the Effective Date. Millipore and Entegris agree to meet
annually beginning on the anniversary date of this Agreement to discuss measures each party might take which would be designed potentially to increase the above stated production capacities. 

  

	4.3.	Capacity Expansion. 

  

	 	4.3.1.	Membrane manufacturing capacity will be reviewed in accordance with a mutually agreed upon schedule during the Term of this Agreement, but no less often than annually.
Entegris shall be responsible to review and report on the capacity of the Entegris Equipment and Millipore shall be responsible to review and report on the capacity of the Millipore Equipment. The results of these reviews will be discussed and
documented for reference and to provide a basis for capacity expansion, as may be appropriate and agreed by the parties. 

  

	 	4.3.2.	The parties hereby acknowledge that Entegris has purchased and had installed, on or about August 2005, a third (3rd) NZE Extractor at the Premises for purposes of Membrane manufacture pursuant hereto. Such NZE Extractor is installed in the space within the Premises
which had previously been used by Mykrolis under the Old Agreement to manufacture Hollow Fiber UPE Membranes, as such space was expanded, the increased square footage of which has been reflected in Attachment A. The parties further acknowledge that
Entegris had and has sole responsibility for the purchase, installation and facilitation of such NZE Extractor and all funding therefor, and Entegris is the sole owner thereof. 

  

 Page 8 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	4.4.	Manufacturing Process Improvements. Millipore and Entegris agree to implement the Membrane manufacturing process improvements
described in Article II of the Supplement in accordance with the provisions thereof. 

  

	4.5.	End of Term Arrangements for Millipore. Following the expiration or earlier termination of the Term of this Agreement, Millipore desires the full
capabilities to manufacture (or have manufactured) UPE Membranes for its and its Affiliated Companies’ use and sale, and for its and its Affiliated Companies’ use in manufacturing (or having manufactured) UPE Products for sale.
Accordingly, to facilitate Millipore’s manufacture of UPE Membranes following the Term of this Agreement: 

  

	 	4.5.1	(i) Entegris agrees in the event that Entegris during the Term of this Agreement acquires and has installed at the Premises new equipment in replacement of the existing
Extrusion Line, or otherwise determines during the Term of this Agreement, in its sole discretion, that the Extrusion Line and/or one NZE Extractor are surplus and are to be disposed of, then Entegris agrees to grant Millipore an option to purchase,
prior to or at the termination of this Agreement, at their then current book values and at such other reasonable terms as the parties may agree, such surplus Extrusion Line and/or NZE Extractor. Upon consummation of any such sale transaction,
Entegris agrees to leave in their then current locations at the Premises, the subject Extrusion Line and/or NZE Extractor, as the case may be. Entegris agrees to notify Millipore as to whether it is granting Millipore such an option, at least
eighteen (18) months prior to the termination of this Agreement; and 

  

	 	4.5.2	In the event that the parties consummate a sale of any equipment deemed to be surplus by Entegris as specified above, Entegris agrees to provide Millipore with the know-how
(including copies of all pertinent documentation) and a reasonable amount of transition assistance relating to the design, specifications, functionality, operation and maintenance of such equipment, or otherwise necessary or useful for Millipore to
be able to continue the UPE Membrane manufacturing process immediately upon the termination of this Agreement, so as to be able to make or have made UPE Membrane in the same process and of the same quality as made and supplied under this Agreement.
All Entegris transition assistance time shall be charged to Millipore at the rates per person-hour calculated in accordance with Section 7.3 below. 

  

 Page 9 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	4.6.	End of Term Arrangements for Entegris.  

  
 To facilitate Entegris’ manufacture of UPE Membranes and Treated Entegris Membranes at a different location following the expiration or earlier
termination of this Agreement: 
  

	 	4.6.1.	Entegris shall remove and transport, at its own expense, the Entegris Equipment (subject to the consummation of any sale pursuant to any option to purchase certain items of
such Entegris Equipment as specifically set forth in Subsection 4.5.1 above) from the Premises to a location of its choice within one-hundred eighty (180) days following such expiration or early termination. Entegris shall use its best efforts
to avoid or minimize damage to the Premises or to any other part of Millipore’s 80 Ashby Road facility from such removal, and shall promptly reimburse Millipore for its reasonable and actual costs of repairing any damage to the extent caused by
Entegris or its agents or representatives in the process of removing the Entegris Equipment from the Premises or any other parts of such facility; and, 

  

	 	4.6.2.	Millipore shall provide Entegris with know-how (including copies of all pertinent documentation) and a reasonable amount of transition assistance relating to the design,
specifications, functionality, operation and maintenance of the Millipore Equipment, such that Entegris can make or have made, and operate and maintain, equipment substantially equivalent or comparable to the Millipore Equipment, or successfully
outsource the functions performed by the Millipore Equipment, in the manufacture of UPE Membranes and Treated Other Entegris Membranes. All Millipore transition assistance shall be charged to Entegris at the rates per person-hour calculated in
accordance with Section 7.3 below. 

  

	4.7.	Joint Know-How. In the event that any know-how results from or is developed in the course of the manufacture of UPE Membranes or Treated Other Entegris
Membranes in the Premises during the Term of this Agreement (including the use of Millipore Equipment in such manufacture), whether by employees of Millipore, employees of Entegris or jointly, such know-how shall be jointly owned by Entegris and
Millipore. Millipore shall have rights to use such know-how in all fields other than the Entegris Core Business, and Entegris shall have rights to use such know-how in all fields other than the Millipore Core Business. 

  

	4.8.	Additional Membranes. Entegris shall have the right to add other membranes to the list and definition of “UPE Membranes” during the Term of
this Agreement, subject to (i) Millipore’s approval (on grounds of safety, compliance with laws, or avoidance of damage to the Millipore Equipment, the Premises or any other parts of Millipore’s 80 Ashby Road facility) of the
manufacture of such additional UPE Membranes, which approval shall not be unreasonably withheld or delayed, and (ii) Millipore’s having sufficient space and equipment capacity for such additional manufacture, and (iii) scheduling of
use of the Millipore Equipment as shall be negotiated by the parties in good faith. 

  

 Page 10 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	5.	SUPPLY OF MEMBRANES 

  

	5.1.	Sale of Membrane. Entegris agrees to sell to Millipore Flat Sheet UPE Membranes, in the amounts contained in Millipore’s Releases, at all times
during the Term and, in the event this Agreement is terminated by Entegris pursuant to Section 6.2 (iii), at all times following the Term through and including December 31, 2010 or until any event prior thereto that would have given rise
to Entegris’ right to terminate this Agreement pursuant to Section 6.2 (i) or (ii). Millipore agrees to sell to Entegris, from time to time through and including March 31, 2006, Other Membranes in the amount contained in
Entegris’ Releases. Except as set forth in Section 5.4 hereof, neither party shall have any minimum or maximum purchase requirements for any or all of such Membranes hereunder, either per order or in the aggregate.

  

	5.2.	Terms of Sale. Unless otherwise agreed by both parties in writing, this Agreement applies to all Releases placed by a Supplied Party with a Supplying
Party during the Term. The terms and conditions of this Agreement shall apply to any Release, whether or not this Agreement or its terms and conditions are expressly referenced in the Release. All Membrane shall be tested, inspected and packaged for
delivery by the Supplying Party as mutually agreed by the parties. 

  

	5.3.	Priority. Unless otherwise agreed by both parties in writing for a specific transaction, no inconsistent or additional term or condition in any Release,
or in any acknowledgment, invoice or other document issued by a Supplying Party or its representative in connection with a particular purchase by a Supplied Party, shall be applicable to a transaction within the scope of this Agreement. Both parties
specifically agree that any terms and conditions in any such documents which are in any way inconsistent with this Agreement shall be inapplicable, and the terms of this Agreement shall govern. 

  

	5.4.	Forecasts and Releases. 

  

	 	5.4.1	 Millipore will provide Entegris with a rolling one-year forecast of its demand for UPE Membranes hereunder, by calendar quarter (a “One-Year
Forecast”), which will be updated on a quarterly basis, at least thirty (30) days prior to the start of each calendar quarter. The sub-forecast for the first three (3) months within any One-Year Forecast shall be referred to as a
“3 Month Forecast”. Millipore must provide Releases for delivery, during the three (3) months covered by any 3 Month Forecast, of UPE Membranes in at least those quantities set forth in such 3 Month Forecast. Except for such semi
binding nature of the 3 Month Forecasts as described more specifically at 5.4.4 below, the One-Year Forecasts will be used for planning purposes only and are not binding. Entegris will ship UPE 

  

 Page 11 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
Membranes so as to arrive on the delivery date set forth in a Release, provided that the delivery date set forth in such Release is not less than thirty
(30) days following the date Entegris receives such Release and provided that the quantities set forth in such Release, together with those in all other Releases calling for delivery during the same quarter, are not more than thirty percent
(30%) greater than the quantities provided in the applicable 3 Month Forecast. For any Releases calling for quantities more than thirty percent (30%) greater than the quantities provided in such 3 Month Forecast, Entegris shall use
commercially reasonable efforts to deliver such quantities within thirty (30) days following the date Entegris receives such release or as soon as practicable thereafter. 

  

	 	5.4.2	Within ten (10) days after receipt of each One Year Forecast, Entegris will provide a non-binding, good faith projection of its UPE Membrane manufacturing volume (broken
down between philic and phobic Membranes), by calendar quarter, for the upcoming four calendar quarters. This information will be used by Millipore for budgeting of resources and revenue, and for the determination of budgeted Machine Hourly Rates
for purposes of Section 7.1.2. 

  

	 	5.4.3	Entegris’ forecasting and Releases to Millipore for Other Membranes for all periods hereunder in which such supply obligations remain in effect shall proceed pursuant to
the provisions of this Section 5.4.3. Entegris will provide Millipore with a rolling one-year forecast of its demand for Other Membranes hereunder, by calendar quarter (the “Entegris Annual Forecast”), which will be updated on a
quarterly basis, at least thirty (30) days prior to the start of each calendar quarter. The sub-forecast for the first three (3) months within any Entegris Annual Forecast shall be referred to as a “One Quarter Forecast”.
Entegris must provide Releases for delivery, during the three (3) months covered by any One Quarter Forecast, of Other Membranes not more than zero percent (0%) less or thirty percent (30%) greater than the quantities set forth in such One
Quarter Forecast. Except for such commitment with respect to the One Quarter Forecasts, the Entegris Annual Forecasts will be used for planning purposes only and are not binding. Millipore will ship Other Membranes so as to arrive on the delivery
date set forth in a Release, provided that the delivery date set forth in such Release is not less than thirty (30) days following the date Millipore receives such Release and provided that the quantities set forth in such Release, together
with those in all other Releases calling for delivery during the same quarter, are within the range provided above in accordance with the applicable One Quarter Forecast. 

  

	 	5.4.4	 Millipore’s requirements for membranes for an upcoming quarter shall be submitted to Entegris in the form of purchase orders before the start of that quarter.
Millipore shall be entitled to cancel orders without penalty or 

  

 Page 12 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
other change if the written cancellation notice is received by Entegris prior to the ordered membrane lot being extruded. Millipore shall be entitled to
increase volume of membrane ordered during the quarter by issuing a supplemental purchase order and Entegris agrees to make reasonable efforts to accommodate the requested additional volume. 

  

	5.5.	Prices; Delivery and Payment Terms. Membrane prices shall be as set forth in Section 7.5 hereof. Payment terms for the sale of Membranes hereunder
shall be as set forth in Section 7.6 hereof. Delivery terms for all Membranes will be FOB 80 Ashby Road, Bedford, MA. 

  

	6.	TERM AND TERMINATION 

  

	6.1.	The effective period of this Agreement (the “Term” or “Term of this Agreement”) shall begin on the Effective Date and continue thereafter until
December 31, 2010 or until earlier termination in accordance with Section 6.2. Any Release issued by a Supplied Party before the effective date of termination and in accordance with Section 5.4 hereof shall be fulfilled by the
Supplying Party. 

  

	6.2.	Either party may terminate this Agreement prior to December 31, 2010 without prejudice to any rights or liabilities accruing up to the date of termination:

  

	 	(i)	in the event of a material breach by the other party of any of the terms and conditions of this Agreement, by giving the other party written notice of such breach, provided
that such breach shall not have been cured within one hundred twenty (120 ) days following such notice; or, 

  

	 	(ii)	immediately, by written notice thereof, if any of the following events or an event analogous thereto occurs: 

  

	 	a.	an adjudication has been made that the other party is bankrupt or insolvent; 

  

	 	b.	the other party has filed bankruptcy proceedings or has had such proceedings filed against it, except as part of a bona fide scheme for reorganization; 

  

	 	c.	a receiver has been appointed for all or substantially all of the property of the other party; 

  

	 	d.	the other party has assigned or attempted to assign this Agreement for the benefit of its creditors; or 

  

	 	e.	the other party has begun any proceeding for the liquidation or winding up of its business affairs; or, 

  

	 	(iii)	at any time for convenience of the terminating party upon twenty-four (24) months prior written notice to the other party. 

  

 Page 13 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	6.3.	Termination under this Section 6 shall be in addition to and not a substitute for other rights or causes of action of the terminating party. 

  

	6.4.	Termination of this Agreement shall not in any way operate so as to impair or destroy any of the rights or remedies of either party, either at law or in equity, nor shall it
relieve the parties of their obligations pursuant to Sections 1, 3.1, 4.5, 4.6, 4.7, 5.1,5.2, 5.3,6, 8, 9, 12, 13, 14 ,15 and 16 hereof, each of which shall survive the termination or expiration of this Agreement. 

  

	7.	PRICES AND PAYMENTS  

  

	7.1.	Machine Hourly Rates. The hourly rates (“Machine Hourly Rates”) for use by Entegris of Millipore’s VMF4 Line, Film 1 Annealing Line and
Mix Room equipment (the “Machines”), and the invoicing thereof, shall be as set forth in this Section 7.1. Machine usage (including production and research and development usage) shall be calculated in accordance with the formula set
forth in Annex 2. 

  

	 	7.1.1.	Machine Hourly Rates. Commencing on the Effective Date, the Machine Hourly Rates that are currently in use by the parties during 2005 shall be applicable from
the Effective Date through December 31, 2005. Commencing on January 1, 2006, the Machine Hourly Rates set forth in Annex 1, subject to the annual adjustments as set forth below in this Section, shall be applicable from the Effective Date
through the end of the period of the Term of this Agreement. The Machine Hourly Rates shall be adjusted annually as of January 1 of each year, beginning in calendar year 2007, to reflect (i) the then most recent August-to-following-August
percentage changes, up or down, in the Producer Price Index for the industry group Pharmaceutical Preparation Manufacturing (series identification number PCU325412325412), (ii) any demonstrated increases in Millipore’s costs associated
directly with use of the Machines hereunder and which costs are extraordinary, not presently anticipated and not reflected in the Producer Price Index used pursuant to clause (i) above, and (iii) changes to depreciation charges as a result
of capital improvements to the Machines for the production of Membranes, as set forth in Section 7.4.2. Machine Hourly Rates to Entegris are independent of Millipore production volumes on the Machines. 

  

	 	7.1.2.	 Invoicing for Machine Hourly Rates. Millipore shall be entitled to invoice Entegris monthly for Machine usage following the end of each
month. The Machine Hourly Rates used for the first two months of each calendar quarter shall be the average Machine Hourly Rates that would apply for the budgeted use of each Machine for such quarter, as calculated by Millipore based on the then
most recent projections provided by Entegris pursuant to Section 5.5.2 hereof. The invoice for the third month of each calendar quarter shall be adjusted to effect a “true up” to actual Machine usage by invoicing for the net
difference between the Machine Hourly Rate applicable to the actual hourly usage of the Machine in question for 

  

 Page 14 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
the entire quarter multiplied times the actual hours of usage of such Machine for the quarter less the amounts invoiced for usage of such Machine for the
first two months of the quarter. This “true up” is so that Entegris effectively pays for all of a quarter’s hours at the Machine Hourly Rates appropriate for those total hours. 

  

	7.2.	Occupancy Rates. Commencing on the Effective Date, rates for occupancy and use of the Premises shall be as set forth in Exhibit
B. 

  

	7.3.	Support Rates. Commencing on the Effective Date, rates for extraordinary Millipore supervisory, operational assistance and technical
support (as described in Section 3.2 hereof) that are currently in use by the parties during 2005 shall be applicable from the Effective Date through December 31, 2005. Commencing on January 1, 2006, rates for extraordinary Millipore
supervisory, operational assistance and technical support (as described in Section 3.2 hereof) shall be as shown in Annex 1. These rates will be adjusted annually as of January 1 of each year, beginning in calendar year 2007, to reflect
(i) the then most recent August-to-following-August percentage changes, up or down, in the Producer Price Index for the industry group Pharmaceutical Preparation Manufacturing (series identification number PCU325412325412) and (ii) any
demonstrated increases in Millipore’s costs associated directly with providing such support hereunder and which costs are extraordinary, not presently anticipated and not reflected in the Producer Price Index used pursuant to clause (i) above.

  

	7.4.	Impact of Capital Investment on Prices. 

  

	 	7.4.1.	Entegris shall be responsible for funding required capital improvements to the Entegris Equipment for production of hydrophobic Membranes. Millipore shall be responsible for
funding required capital improvements to the Millipore Equipment for production of hydrophilic Membranes. To the extent that capital improvements are required for the Millipore Equipment used in the production of hydrophobic Membranes,
responsibility for funding that capital improvement shall be mutually agreed upon in accordance with Section I.1.7 of the Supplement. If one party funds the purchase of additional equipment for use in manufacture of UPE Membranes at the Premises,
that equipment shall be owned by the funding party. 

  

	 	7.4.2.	Changes to depreciation charges as a result of capital improvements to the Equipment for the production of Membranes will be reflected in the appropriate work center rates
and would be part of the rate adjustment process set forth in Sections 7.1.2 and 7.3. Millipore and Entegris each agree to inform the other of capital purchases that may eventually affect proposed rate/price changes hereunder no later than the time
that purchase orders for such capital purchases are placed. 

  

 Page 15 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	7.4.3.	Millipore shall have approval authority with respect to any Entegris proposed modifications to VMF 4 equipment for UPE Membrane processing. Millipore agrees that proposed
modifications to the VMF4 equipment for non-Entegris UPE Membrane processing that could influence the processing of UPE Membranes on the VMF 4 equipment shall be reviewed with Entegris and shall be subject to mutual agreement.

  

	 	7.4.4.	Millipore shall have approval authority for any Entegris proposed modifications to Film 1 manufacturing process for UPE Membranes. Financial impact of those modifications
would be mutually agreed upon prior to proceeding. 

  

	 	7.4.5.	In the event of a process change to either the Film 1 or VMF4 lines, Millipore shall be responsible for change control management for any impact on Millipore products.
Likewise, Entegris would be responsible for change control management for any impact on Entegris products. 

  

	7.5.	Membrane Prices. 

  

	 	7.5.1.	Prices for Other Membranes to Entegris shall be at Millipore’s fully burdened manufacturing cost for such Other Membranes, consistent with U.S. Generally Accepted
Accounting Principles (“Manufacturing Cost”), plus twenty percent (20%), which pricing shall remain for all periods hereunder in which such supply obligations remain in effect. 

  

	 	7.5.2.	Commencing on the Effective Date through December 31, 2005, prices for Flat Sheet UPE Membranes to Millipore shall be at Entegris’ Manufacturing Cost plus twenty
percent (20%). Commencing on January 1, 2006 until adjusted pursuant to Section 7.5.3, prices for Flat Sheet UPE Membranes to Millipore shall be at Entegris’ Manufacturing Cost plus fifteen percent (15%). 

  

	 	7.5.3.	Within thirty (30) days following the Effective Date for purposes of determining Manufacturing Costs of Flat Sheet UPE Membranes to be in effect for 2006, and on or
before November 15 of each year during the Term thereafter for which a Supplying Party’s Membrane supply obligations will continue hereunder during the following year, beginning with 2007, each Supplying Party shall notify the other party
as to the adjusted Manufacturing Cost to be in effect for the following calendar year for the Membranes to be supplied by such Supplying Party and shall make available an “open-book” review of such Manufacturing Cost. Membrane Prices
hereunder will be adjusted as of January of each year during the Term to reflect such adjusted Manufacturing Cost. Without limiting the factors involved in determining Manufacturing Cost, the Manufacturing Cost of UPE Membranes shall take into
account the budgeted Machine Hourly Rates based on projected annual UPE Membrane manufacturing volume. 

  

 Page 16 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	7.6.	Payment of Invoices. All amounts payable by either party to the other pursuant to this Agreement, except for amounts payable as Rent, shall be payable
within forty-five (45) days following the later of (i) receipt of ordered Membranes, performance of services or Machine usage, and (ii) receipt of invoice. All payments shall be made in U.S. Dollars. Any late payments shall be subject
to interest at a rate of twelve percent (12%) per annum. 

  

	8.	NON-COMPETITION 

  
 Except as otherwise provided in Article 5 hereof or elsewhere in this Agreement: 

 

	8.1.	Millipore agrees that neither it nor any of its Affiliated Companies will (i) sell outside of the Millipore Core Business any UPE Membranes or UPE Products, or
(ii) sell any UPE Membranes or UPE Products to any distributor, OEM manufacturer or other third party that has rights to, or that Millipore or any such Affiliated Company has reason to believe will, resell such UPE Membranes or UPE Products
outside of the Millipore Core Business or sell other products which include UPE Membranes or UPE Products as materials or components outside of the Millipore Core Business. 

  

	8.2.	Entegris agrees that neither it nor any of its Affiliated Companies will (i) sell into the Millipore Core Business any Other UPE Membranes or Other UPE Products, or
(ii) sell any Other UPE Membranes or Other UPE Products to any distributor, OEM manufacturer or other third party that has rights to, or that Entegris or any such Affiliated Company has reason to believe will, resell such Other UPE Membranes or
Other UPE Products into the Millipore Core Business or sell other products which include Other UPE Membranes or Other UPE Products as materials or components into the Millipore Core Business. 

  

	8.3.	Up to and until March 31, 2006, Millipore agrees that neither it nor any of its Affiliated Companies will (i) sell into the Entegris Core Business any Other
Membranes or Other Membrane Products, or (ii) sell any Other Membranes or Other Membrane Products to any distributor, OEM manufacturer or other third party that has rights to, or that Millipore or any such Affiliated Company has reason to
believe will, resell such Other Membranes or Other Membrane Products into the Entegris Core Business or sell other products which include Other Membranes or Other Membrane Products as materials or components into the Entegris Core Business.

  

	8.4.	 Up to and until March 31, 2006, Entegris agrees that neither it nor any of its Affiliated Companies will (i) sell into the Millipore Core Business
any Other Membranes or Other Membrane Products, or (ii) sell any Other Membranes or Other Membrane Products to any distributor, OEM manufacturer or other third 

  

 Page 17 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
party that has rights to, or that Entegris or any such Affiliated Company has reason to believe will, resell such Other Membranes or Other Membrane Products
into the Millipore Core Business or sell other products which include Other Membranes or Other Membrane Products as materials or components into the Millipore Core Business. 

  

	8.5.	Entegris agrees that neither it nor any of its Affiliated Companies will (i) sell outside of the Entegris Core Business any Treated Entegris Membranes or Treated
Entegris Products, or (ii) sell any Treated Entegris Membranes or Treated Entegris Products to any distributor, OEM manufacturer or other third party that has rights to, or that Entegris or any such Affiliated Company has reason to believe
will, resell such Treated Entegris Membranes or Treated Entegris Products outside of the Entegris Core Business or sell other products which include Treated Entegris Membranes or Treated Entegris Products as materials or components outside of the
Entegris Core Business. 

  

	8.6.	In the event that either party discovers any distribution arrangements pre-existing the Separation Date that would conflict with the provisions of this Agreement, the parties
agree that any such pre-existing arrangements shall not constitute a breach hereunder, and they further agree: (i) to use reasonable commercial efforts to cause any such terms of distribution agreements that are inconsistent with the provisions
contained herein to be amended so as to be consistent with these provisions, (ii) not to amend any distribution agreements following the date of this Agreement so as to be inconsistent with such provisions, and (iii) not to renew or enter
into any distribution agreements or other agreements containing terms inconsistent with the provisions contained herein following the date of this Agreement. 

  

	8.7.	 It is acknowledged and accepted that either party or its Affiliated Companies may from time to time hereafter unintentionally make sales that would be
prohibited in accordance with Sections 8.1 through 8.5 (“Sales Outside Field”). Accordingly, notwithstanding Sections 8.1 through 8.5, each party agrees not to actively market or attempt to make Sales Outside Field, provided that
for any Sales Outside Field that are nevertheless made by and known to a party, such party shall, within forty-five (45) days following the end of each calendar year in which such Sales Outside Field were made, provide an accounting of its
Gross Margins on such Sales Outside Field during such calendar year (such accounting to include the total amount of such Sales Outside Field, the total Gross Margins on such Sales Outside Field, and detail regarding the customers to which such Sales
Outside Field were made) and payment of the amount of such Gross Margins to the other party. Other than such accountings, neither party shall be liable for any commission, payment, remittance, accrual or obligation or incur any other liability to
the other party with respect to any such Sales Outside Field. For purposes of this Section, “Gross Margins” on a party’s Sales Outside Field shall mean the sale price, net of discounts and other sales deductions, of a Membrane or

  

 Page 18 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
product sold Outside Field, less such party’s fully burdened manufacturing cost of such Membrane or product (which for Membranes purchased from the
other party hereunder shall mean the price paid to the other party for such Membranes). 

  

	9.	WARRANTIES AND INDEMNIFICATION 

  

	9.1.	Each Supplying Party warrants to the corresponding Supplied Party that: 

  

	 	(i)	All Membranes supplied to the Supplied Party hereunder shall conform to the specifications for such Membranes as in effect as of the date of this Agreement and as provided to the
Supplied Party, as such specifications may be amended as agreed by the parties ; 

  

	 	(ii)	All Membranes supplied hereunder shall be free of defects in materials and workmanship; and 

  

	 	(iii)	It will abide by all applicable laws and regulations in manufacturing and supplying Membranes pursuant to this Agreement. 

  

	9.2.	In the event of a breach of the foregoing warranties, the Supplying Party’s sole obligation to the Supplied Party shall be to repair, replace or refund, at the Supplying
Party’s option, any non-conforming Membranes. 

  

	9.3.	THE SUPPLYING PARTY MAKES NO OTHER WARRANTY, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE. FURTHERMORE, THE
SUPPLYING PARTY SHALL NOT BE LIABLE FOR CONSEQUENTIAL, INCIDENTAL, SPECIAL OR ANY OTHER INDIRECT DAMAGES RESULTING FROM ECONOMIC LOSS OR PROPERTY DAMAGE SUSTAINED BY THE SUPPLIED PARTY FROM THE USE OF THE SUPPLIED MEMBRANES.

  

	9.4.	Each Supplying Party agrees to indemnify and hold the corresponding Supplied Party harmless from and against any claim or legal action by a third party against such Supplied
Party (including reasonable attorneys’ fees associated therewith) based on damages incurred as a result of property damages, personal injury or death, to the proportionate extent arising from a breach of any of the above warranties of the
Supplying Party or from the Supplying Party’s negligent action or omission. 

  

	9.5.	 Without limiting any other rights or remedies that a Supplied Party may have, if such Supplied Party determines that delivered Membranes do not conform to
the agreed specifications for such Membranes, then such Supplied Party may reject or withdraw its acceptance thereof and shall notify the Supplying Party in writing of such nonconformity or error within thirty (30) days from receipt of such
Membranes by the Supplied Party. The Supplied Party may subject any 

  

 Page 19 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
Membrane to internal testing for purposes of determining conformity to specifications. The Supplying Party shall have fifteen (15) days after receipt of
written notice of nonconformity or error to replace nonconforming Membranes at the expense of the Supplying Party. If so directed by the Supplying Party, the Supplied Party shall return nonconforming Membranes to the Supplying Party’s
manufacturing facilities, at the Supplying Party’s expense and using such carrier and such delivery dates and terms as the Supplying Party shall reasonably specify. 

  

	9.6.	The parties agree to have their representatives meet at least once every three (3) months (unless otherwise agreed) to review compliance with the manufacturing,
specifications, product quality, forecasting and delivery terms set forth in this Agreement, and to agree on any necessary corrective actions or modifications to the Supplement as then in effect. 

  

	10.	MEMBRANE MODIFICATIONS; NEW MEMBRANES. 

  

	10.1.	Each Supplying Party agrees that it will not substantially change the Membranes that it will supply hereunder or their formulation, manufacturing or testing processes,
process equipment, other aspects of form, fit or function, or production location, unless the Supplied Party approves such change in writing, which approval may require formal validation and qualification and possibly customer notification. The
implementation of any such accepted changes shall be subject to the parties’ agreement on any change in price or other terms of supply as may be necessitated or requested by a party as a result of such change. 

  

	10.2.	If any new or improved UPE Membranes result from research and development work that may be conducted by either Millipore or Entegris during the Term of this Agreement, or are
requested by Millipore to be added to the supply provisions hereof, and are agreed to by Entegris, and are technically feasible for Entegris to manufacture, it is intended that such UPE Membranes be added to this Agreement both in terms of
Entegris’ supply to Millipore and Entegris’ manufacture of such UPE Membranes, and they shall be so added to this Agreement upon agreement by the parties as to specifications and pricing, which pricing shall be consistent in methodology
with the pricing hereunder. 

  

	11.	ACCESS TO FACILITIES 

  
 At any time during the Term, upon reasonable advance notice by a Supplied
Party, such Supplied Party’s authorized representatives and customers (subject to appropriate confidentiality obligations) shall be provided access to the facilities of the Supplying Party to audit or verify conformity with applicable laws and
regulations and mutually agreed to quality standards. During the Term of this Agreement, Millipore’s authorized representatives shall be provided access to the Premises for the purpose of auditing or troubleshooting (to be coordinated with
Entegris) of technical problems with UPE Membranes or their manufacture. Also, during the Term of this Agreement, Millipore and Entegris customers 

  

 Page 20 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
(subject to appropriate confidentiality obligations and on reasonable advance notice, and for the purposes indicated above) shall be provided reasonable
access, respectively, to the Premises and to the areas of Millipore’s 80 Ashby Road facility where the Millipore Equipment is located and used. 

  

	12.	INSURANCE RELATED TO MEMBRANES  

  

	  	Each Supplying Party agrees to procure and maintain, at all times during the Term, product liability insurance with respect to the Membranes supplied by it (Broad Form Vendor’s
Endorsement) and contractual liability coverage, with the minimum limits of $5,000,000 (Five Million Dollars). Each Supplying Party shall, upon request by the Supplied Party, furnish to the Supplied Party a certificate of insurance evidencing the
foregoing coverage and limits. The insurance provider shall not be changed without providing the Supplied Party with ten (10) days’ prior written notice. 

  

	13.	CONFIDENTIALITY 

  

	13.1.	Confidential Information. For the purpose of this Agreement the term “Confidential Information” means Information which is not
otherwise in the public domain and of which the owner actively undertakes to restrict or control the disclosure to persons or entities other than Millipore or Entegris or their Subsidiaries in a manner reasonably intended to maintain its
confidentiality, and which: (i) the party owning or disclosing Confidential Information (“Disclosing Party”) disclosed to the non-owning party or recipient of the Confidential Information (“Receiving Party”) or the
Receiving Party had access to on or before the Separation Date; (ii) is contained in or referred to by this Agreement or any exhibit or annex hereto and is known to or in the possession of the Receiving Party as of the Effective Date; or
(iii) is disclosed to the Receiving Party pursuant to this Agreement during the Term (the “Disclosure Period”). Confidential Information may include information relating to, by way of example, research, products, services,
customers, markets, software, developments, inventions, manufacturing processes, designs, drawings, engineering, marketing or finances, and may be in writing, disclosed orally or learned by inspection of computer programming code, equipment or
facilities. Confidential Information of third parties that is known to, in the possession of or acquired by a Receiving Party pursuant to a relationship with the Disclosing Party shall be deemed to be the Disclosing Party’s Confidential
Information for purposes of this Section 13. 

  

	 	13.1.1.	 Highly Confidential Information means Confidential Information that is technical know-how and trade secrets relating to:
(i) Information relating to manufacturing processes or procedures with respect to devices or other products that are commercially released or for which substantial steps have been taken towards commercialization as of the Effective Date;
(ii) Information generated by research and development activities; (iii) chemical and other scientific formulae 

  

 Page 21 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	 	 
used for the manufacture or treatment of membranes or other separations media or of devices or other products that are commercially released or for which
substantial steps have been taken towards commercialization as of the Effective Date; or (iv) any other Information which Millipore and Entegris agree is Highly Confidential hereunder. 

  

	 	13.1.2.	Exclusions from Confidential Information. Notwithstanding the foregoing provisions of this Section 13.1, Confidential Information shall exclude
information that: (i) was in the Receiving Party’s possession before receipt from the Disclosing Party and obtained from a source other than the Disclosing Party and other than through the prior relationship of the Disclosing Party
and the Receiving Party before the Separation Date; (ii) is or becomes a matter of public knowledge through no fault of the Receiving Party; (iii) is rightfully received by the Receiving Party from a third party without a
duty of confidentiality; (iv) is disclosed by the Disclosing Party to a third party without a duty of confidentiality on such third party; (v) is independently developed by the Receiving Party; or (vi) is publicly
disclosed by the Receiving Party with the Disclosing Party’s prior written approval. 

  

	13.2.	Confidentiality And Non-Use Obligations. During the Confidentiality Period (as defined in Section 13.3 below), the Receiving Party shall
(i) protect the Confidential Information of the Disclosing Party by using the same degree of care, but no less than a reasonable degree of care, to prevent the unauthorized use, dissemination, or publication of the Confidential
Information as Receiving Party uses to protect its own confidential information of a like nature, (ii) not use such Confidential Information in violation of any use restriction herein, and (iii) not disclose such Confidential
Information to any third party, except as expressly permitted under this Agreement or in any other agreements entered into between the parties in writing, without prior written consent of the Disclosing Party. 

  

	13.3.	Duration of Confidentiality Obligations. The confidentiality obligations provided for in this Section 13 shall continue in effect for the
following periods (the “Confidentiality Period”): (i) with respect to Confidential Information that is not Highly Confidential Information, for a period of five (5) years following either (A) the Effective Date with respect
to Confidential Information of the Disclosing Party that is known to or in the possession of the Receiving Party as of the Effective Date or (B) the date of disclosure with respect to Confidential Information that was or will be disclosed by
the Disclosing Party to the Receiving Party after the Effective Date but before the expiration of the Disclosure Period (as defined in Subsection 13.1 above); and (ii) with respect to Highly Confidential Information, in perpetuity. The
obligations set forth in this Section 13 shall survive any termination of this Agreement. 

  

 Page 22 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	13.4.	Compelled Disclosure. If the Receiving Party or any of its respective Subsidiaries believes that it will be compelled by a court or other
authority of competent jurisdiction to disclose Confidential Information of the Disclosing Party, it shall give the Disclosing Party prompt written notice so that the Disclosing Party may take steps to oppose such disclosure and cooperate with the
Disclosing Party in its attempts to oppose such disclosure. If the Receiving Party complies with the preceding sentence, it shall not be prohibited from complying with such requirement to disclose, but shall take all reasonable steps to make such
disclosure subject to a suitable protective order or otherwise to prevent unrestricted or public disclosure. 

  

	13.5.	No Restriction on Disclosing Party. Nothing in this Section 13 shall restrict the Disclosing Party from using, disclosing, or
disseminating its own Confidential Information in any way. 

  

	13.6.	Disclaimer of Warranties as to Confidential Information. EACH PARTY ACKNOWLEDGES AND AGREES THAT ALL
CONFIDENTIAL INFORMATION IS PROVIDED ON AN “AS IS, WHERE IS” BASIS AND THAT NEITHER PARTY NOR ANY OF ITS SUBSIDIARIES HAS MADE OR WILL MAKE ANY WARRANTY WHATSOEVER, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, ENFORCEABILITY OR NON-INFRINGEMENT. 

  

	14.	NO OTHER RIGHTS 

  
 Neither party shall have any rights hereunder to any patents or other intellectual property of the other party, except as
specifically set forth herein. Without limiting the generality of the foregoing, neither party shall have any rights to use any trademarks of the other party for any purpose in connection with the Membranes to be manufactured or supplied hereunder.

  

	15.	DISPUTE RESOLUTION 

  

	15.1.	Discussion of Parties. In the event of a dispute between the parties arising out of or related to this Agreement (the “Dispute”),
a party seeking to resolve the Dispute shall give written notice to the other party, describing briefly the nature of the Dispute and its claim and identifying an individual with authority to settle the Dispute on its behalf. The party receiving
such notice shall have five (5) business days within which to designate, in a written notice given to the initiating party, an individual with authority to settle the Dispute on its behalf. Neither of such authorized individuals shall have had
direct substantive involvement in the matters involved in the Dispute. The authorized individuals shall make such investigation as they deem appropriate and thereafter promptly (but in no event later than thirty (30) days from the date of the
initiating party’s notice) shall commence discussions concerning resolution of the Dispute. 

  

 Page 23 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	15.2.	If the Dispute has not been resolved within thirty (30) days from the commencement of discussions, it shall be submitted to final and binding arbitration under the then
current Commercial Arbitration Rules of the American Arbitration Association (“AAA”), by one (1) arbitrator in Boston, Massachusetts. Such arbitrator shall be selected by the mutual agreement of the parties or, failing such agreement,
shall be selected according to the aforesaid AAA rules. The arbitrator will be instructed to prepare and deliver a written, reasoned opinion stating its decision within thirty (30) days of the completion of the arbitration. The prevailing party
in such arbitration shall be entitled to expenses, including costs and reasonable attorneys’ and other professional fees, incurred in connection with the arbitration. The decision of the arbitrator shall be final and non-appealable and may be
enforced in any court of competent jurisdiction. 

  

	15.3.	Continuity of Service and Performance. Unless otherwise agreed in writing, the parties will continue to provide service and honor all other commitments
under this Agreement during the course of dispute resolution pursuant to the provisions of this Section 15 with respect to all matters not subject to such dispute, controversy or claim. 

  

	16.	GENERAL PROVISIONS 

  

	16.1.	Notices. Any notice or other communication required or permitted to be given by either party pursuant to the terms of this Agreement shall
be in writing and shall be deemed given if and when delivered by hand or sent by certified mail, return receipt requested, overnight courier, confirmed telecopy, or confirmed electronic mail transmission, addressed as follows:

  

			
	If to Millipore:	  	Millipore Corporation
	 	  	290 Concord Road
	 	  	Billerica, MA 01821
	 	  	Attn: Vice President, Global Supply Chain
	 	  	Fax: (978) 715-1385
		
	with a copy to:	  	Millipore Corporation
	 	  	290 Concord Road
	 	  	Billerica, MA 01821
	 	  	Attn: General Counsel
	 	  	Fax: (978) 715-1382
		
	If to Entegris:	  	Entegris, Inc.
	 	  	129 Concord Road
	 	  	Billerica, MA 01821
	 	  	Attn: VP Global Supply Chain
	 	  	Fax: (978) 436-6739
		
	with a copy to:	  	Entegris, Inc.
	 	  	129 Concord Road
	 	  	Billerica, MA 01821
	 	  	Attn: General Counsel
	 	  	Fax: (978) 436-6739

  

 Page 24 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

 or to such electronic mail address as may be specified by an addressee party to the other party by
one of the other means provided above, or to such other address, telecopy number or electronic mail address as may be specified by an addressee party to the other by one of the means provided above. 
  

	16.2.	Force Majeure. The obligations of a party under this Agreement will be suspended to the extent that it is wholly or partially precluded
from complying with its obligations under this Agreement by force majeure. Force majeure includes, but is not restricted to, fire, storm, flood, earthquake, explosion, accident, act of the public enemy, war, rebellion, insurrection, sabotage,
epidemic, quarantine restriction, labor dispute, labor shortage, transportation embargo or failure or delay in transportation, act of God, act (including laws, regulations, disapprovals or failure to approve) of any government agency, whether
national, municipal, or otherwise. During the existence of any such force majeure condition, the affected party shall nevertheless use its best efforts to remove the cause thereof. 

  

	16.3.	Entire Agreement; Old Agreement. This Agreement, including Exhibits A, B, and C and Annexes 1 and 2, attached hereto, is the
entire agreement between the parties with respect to the subject matter hereof, and supersedes any prior negotiations and agreements or understandings and any contemporaneous oral agreements or understandings with respect to the subject matter
hereof. Without limiting the generality of the foregoing, the Old Agreement shall be deemed replaced in its entirety by this Agreement as of the Effective Date, provided that the Old Agreement shall continue to apply to all activities or events that
occurred prior to the Effective Date. 

  

	16.4.	Governing Law. This Agreement shall be construed in accordance with and all Disputes hereunder shall be governed by the laws of the
Commonwealth of Massachusetts as applied to transactions taking place wholly within Massachusetts between Massachusetts residents. The Superior Court of Middlesex County and/or the United States District Court for the District of Massachusetts shall
have jurisdiction and venue over all Disputes between the parties that are permitted to be brought in a court of law pursuant to Section 15 above. 

  

	16.5.	Counterparts. This Agreement and the Exhibits and Annexes hereto and the other documents referred to herein, may be executed in
counterparts, each of which shall be deemed to be an original but all of which shall constitute one and the same agreement. 

  

 Page 25 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	16.6.	Binding Effect; Assignment. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective legal
representatives and successors, and nothing in this Agreement, express or implied, is intended to confer upon any other person any rights or remedies of any nature whatsoever under or by reason of this Agreement. Neither party may assign this
Agreement or any rights or obligations hereunder, without the prior written consent of the other party, and any such assignment shall be void. Notwithstanding the foregoing, either party may assign this Agreement and all (but not less than all) of
its rights and obligations hereunder to a purchaser or transferee of, or other successor to, substantially all of its business. 

  

	16.7.	Severability. If any term or other provision of this Agreement or the Exhibits or Annexes attached hereto is determined by a court,
administrative agency or arbitrator to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to either party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the fullest
extent possible. 

  

	16.8.	Failure or Indulgence Not Waiver; Remedies Cumulative. No failure or delay on the part of either party hereto in the exercise of any right
hereunder shall impair such right or be construed to be a waiver of, or acquiescence in, any breach of any representation, warranty or agreement herein, nor shall any single or partial exercise of any such right preclude other or further exercise
thereof or of any other right. All rights and remedies existing under this Agreement or the Exhibits and Annexes attached hereto are cumulative to, and not exclusive of, any rights or remedies otherwise available. 

  

	16.9.	Amendment. No change or amendment will be made to this Agreement or the Exhibits or Annexes attached hereto except by an instrument in
writing signed on behalf of each of the parties to such agreement. 

  

	16.10.	Authority. Each of the parties hereto represents to the other that (a) it has the corporate or other requisite power and
authority to execute, deliver and perform this Agreement, (b) the execution, delivery and performance of this Agreement by it have been duly authorized by all necessary corporate or other actions, (c) it has duly and validly
executed and delivered this Agreement, and (d) this Agreement is a legal, valid and binding obligation, enforceable against it in accordance with its terms subject to applicable bankruptcy, insolvency, reorganization, moratorium or other
similar laws affecting creditors’ rights generally and general equity principles. 

  

 Page 26 of 27 

 Amended and Restated Membrane Manufacture and Supply Agreement 
 Between Millipore Corporation and Entegris, Inc. dated November 30, 2005 
  

	16.11.	Interpretation. The headings contained in this Agreement or in any Exhibit hereto are for reference purposes only and shall not be
conclusive as to the meaning or interpretation of this Agreement. When a reference is made in this Agreement to a Section, Exhibit or Annex, such reference shall be to a Section, Exhibit or Annex of this Agreement unless otherwise indicated.

  

	16.12.	Exhibits and Annexes. This Agreement includes the following Exhibits and Annexes, each of which constitutes an integral component part of
this Agreement: 

  

			
	 Exhibit A.
	    	Membranes Covered by Agreement
	 Exhibit B
	    	Lease Terms including Attachment A
	 Exhibit C
	    	The Supplement
	 Annex 1
	    	Machine Hourly Rates and Support Rates
	 Annex 2
	    	Formula for Calculating Machine Usage Hours

  
 IN WITNESS
WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives effective as of the Effective Date. 
  

									
	MILLIPORE CORPORATION	 	 	 	ENTEGRIS, INC.
					
	By:	 	 /s/ Peter C. Kershaw

	 	 	 	By:	 	 /s/ Bertrand Loy

	Name:	 	Peter C. Kershaw	 	 	 	Name:	 	Bertrand Loy
	Title:	 	Corporate Vice President of Manufacturing	 	 	 	Title:	 	 Executive Vice President and
 Chief Administrative
Officer

					
	Date:	 	November 30, 2005	 	 	 	Date:	 	November 30, 2005

  

 Page 27 of 27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]